Project/Area Number |
16H07001
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Neurology
|
Research Institution | Hiroshima University |
Principal Investigator |
Ito Hikaru 広島大学, 医歯薬保健学研究科(医), 助教 (50587392)
|
Research Collaborator |
Asakura Atsushi University of Minnesota, Department of Neurology, Stem Cell Institute, Associate Professor
Asakura Yoko University of Minnesota, Department of Neurology, Stem Cell Institute, Technical staff(Researcher2)
|
Project Period (FY) |
2016-08-26 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 再生医療 / 骨格筋幹細胞 / 胚盤胞胚補完法 / 発生工学 / 筋ジストロフィー / サルコペニア / 骨格筋 / キメラ / 再生医学 / 老化 / 移植・再生医療 / 発生・分化 / 動物 / 細胞・組織 |
Outline of Final Research Achievements |
One attractive therapy is myogenic stem cell transplantation to provide dystrophin in Duchenne Muscular Dystrophy (DMD) patients. Recent work has reported the induced pluripotent stem cell (iPSC)-derived myogenic stem cell transplantation for therapeutic strategy for DMD. However, there is a limitation in this strategy, especially in low differentiation efficiency and poor reproducibility of iPSCs-derived myogenic stem cells. Therefore, in a blastocyst complementation method, the regeneration of an organ can be achieved by utilizing the defect in an organ which can be complemented by injecting patient-derived iPSCs into a non-human blastocyst. In this study, we injected GFP (+) mouse iPSCs into skeletal muscle-less mouse blastocysts. iPSC-derived cells highly contributed to limb muscle of chimera. We also performed intramuscular injection of myogenic stem cells isolated from chimeric mice into mdx mice, and detected GFP (+) muscle fibers which also expressed donor-derived dystrophin.
|